AUPH logo

Aurinia Pharmaceuticals (AUPH)

Profile

Full Name

Aurinia Pharmaceuticals Inc.

Ticker Symbol

AUPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

September 3, 2014

Indexes

Not included

Website

http://www.auriniapharma.com

Employees

130

Key Details

Price

$7.67(-1.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$235.13M(+33.97% YoY)

Annual EPS

$0.04(+107.41% YoY)

PE ratio

153.40

Next earnings date

May 2, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.67
AUPH price is $7.67

30-Day Relative Volume

0.70
AUPH 30-day relative volume is 0.70

Price Performance

Price Most recent change

-1.03%
AUPH price was down -1.03% on Apr 16, 2025

Price YTD change

-14.59%
AUPH price is down -14.59% since January 1st

Price 1-year change

+56.21%
AUPH price is up +56.21% year-on-year

Price 3-year change

-35.27%
AUPH price is down -35.27% over the past 3 years

Price Range

Price All-time high

$33.97
AUPH price is currently -77.42% below its historical high of $33.97

Price 3-year low

$4.07
AUPH price is currently +88.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.05B
AUPH market capitalization is $1.05 billion

Market cap 3-year change

-37.28%
AUPH market capitalization is down -37.28% over the past 3 years

Market cap All-time high

$4.29B
AUPH market capitalization is currently -75.42% below its historical high of $4.29 billion

Market cap sector rank

77.06%
AUPH market capitalization is higher than 77.06% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-4.42%
AUPH shares outstanding is down -4.42% year-on-year

Shares Outstanding 3-Year Change

-3.11%
AUPH shares outstanding is down -3.11% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.63
AUPH beta is 0.63

200-day SMA

$7.49
AUPH price is currently +2.44% above its 200-day simple moving average

50-day SMA

$8.03
AUPH price is currently -4.43% below its 50-day simple moving average

RSI

44.79
AUPH 14-day relative strength index is 44.79

Volume

0.70
AUPH 30-day relative volume is 0.70

ATR

$0.32
AUPH average true range is $0.32

10-day Historical Volatility

55.05%
AUPH 10-day historical volatility is 55.05%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$235.13M
AUPH annual revenue is $235.13 million

Revenue Analysts estimate

$258.58M
AUPH annual revenue is currently -9.07% lower than the consensus analysts' forecast

Revenue 1-year change

+33.97%
AUPH annual revenue is up +33.97% year-on-year

Revenue Sector rank

66.18%
AUPH annual revenue is higher than 66.18% of companies in Healthcare sector

EPS

EPS

$0.04
AUPH annual earnings per share is $0.04

EPS Analysts estimate

$0.47
AUPH annual earnings per share is currently -91.40% lower than the consensus analysts' forecast

EPS 1-year change

+107.41%
AUPH annual earnings per share is up +107.41% year-on-year

EPS Sector rank

82.89%
AUPH annual earnings per share is higher than 82.89% of companies in Healthcare sector

Profit

Gross profit

$206.88M
AUPH annual gross profit is $206.88 million

Gross margin

87.99%
AUPH annual gross profit margin is 87.99%

Operating profit

$18.42M
AUPH annual operating income is $18.42 million

Operating margin

7.83%
AUPH annual operating profit margin is 7.83%

Net income

$5.75M
AUPH annual net profit is $5.75 million

Net margin

2.45%
AUPH annual net profit margin is 2.45%

Expenses

Total expenses

$216.71M
AUPH annual total expenses is $216.71 million

Operating expenses

$188.47M
AUPH annual total operating expenses is $188.47 million

Cost of goods sold

$28.25M
AUPH annual cost of goods sold is $28.25 million

Selling, general & administrative expenses

$172.03M
AUPH annual SGA is $172.03 million

Depreciation and amortization

$19.45M
AUPH annual depreciation & amortization is $19.45 million

Interest expense

$4.83M
AUPH annual interest expense is $4.83 million

Income tax

$1.70M
AUPH annual income tax is $1.70 million

EBIT & EBITDA

EBIT

$12.28M
AUPH annual earnings before interest & taxes is $12.28 million

EBITDA

$31.73M
AUPH annual EBITDA is $31.73 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$550.64M
AUPH annual total assets is $550.64 million

Non current assets

$104.05M
AUPH annual long term assets is $104.05 million

Current assets

$446.60M
AUPH annual total current assets is $446.60 million

Cash and cash equivalents

$83.43M
AUPH annual cash & cash equivalents is $83.43 million

Accounts receivable

$36.54M
AUPH annual accounts receivable is $36.54 million

Inventory

$39.23M
AUPH annual inventory is $39.23 million

Liabilities

Total liabilities

$173.17M
AUPH annual total liabilities is $173.17 million

Long term liabilities

$75.40M
AUPH annual total long term liabilities is $75.40 million

Current liabilities

$97.76M
AUPH annual total current liabilities is $97.76 million

Accounts payable

$5.19M
AUPH annual accounts payable is $5.19 million

Debt

Total debt

$79.37M
AUPH annual total debt is $79.37 million

Total debt 1-year change

-18.69%
AUPH annual total debt is down -18.69% year-on-year

Long term debt

$64.30M
AUPH annual long term debt is $64.30 million

Short term debt

$15.07M
AUPH annual short term debt is $15.07 million

Equity & Capital

Shareholders equity

$377.48M
AUPH annual stockholders equity is $377.48 million

Book value

$377.48M
AUPH annual book value is $377.48 million

Retained earnings

-$936.57M
AUPH annual retained earnings is -$936.57 million

Working capital

$348.83M
AUPH annual working capital is $348.83 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$44.39M
AUPH annual cash flow from operations is $44.39 million

Cash from operations 1-year change

+232.66%
AUPH annual cash flow from operations is up +232.66% year-on-year

Cash from investing

$39.26M
AUPH annual cash flow from investing activities is $39.26 million

Cash from investing 1-year change

+685.48%
AUPH annual cash flow from investing activities is up +685.48% year-on-year

Cash from financing

-$49.09M
AUPH annual cash flow from financing activities is -$49.09 million

Cash from financing 1-year change

-856.96%
AUPH annual cash flow from financing activities is down -856.96% year-on-year

CAPEX

CAPEX

$281.00K
AUPH annual capital expenditures is $281.00 thousand

CAPEX 1-year change

-60.86%
AUPH annual capital expenditures is down -60.86% year-on-year

Free Cash Flow

Free cash flow

$44.11M
AUPH annual free cash flow is $44.11 million

Free cash flow 1-year change

+229.05%
AUPH annual free cash flow is up +229.05% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

87.99%
AUPH annual gross profit margin is 87.99%

Operating margin

7.83%
AUPH annual operating profit margin is 7.83%

Net margin

2.45%
AUPH annual net profit margin is 2.45%

ROA & ROE

ROA

1.05%
AUPH annual return on assets is 1.05%

ROE

1.52%
AUPH annual return on equity is 1.52%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

153.40
AUPH price to earnings ratio is 153.40

PE ratio Sector rank

93.14%
AUPH price to earnings ratio is higher than 93.14% of companies in Healthcare sector

PB Ratio

PB ratio

2.79
AUPH price to book ratio is 2.79

PB ratio Sector rank

71.25%
AUPH price to book ratio is higher than 71.25% of companies in Healthcare sector

PS Ratio

PS ratio

4.48
AUPH price to sales ratio is 4.48

PS ratio Sector rank

63.85%
AUPH price to sales ratio is higher than 63.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.05B
AUPH enterprise value is $1.05 billion

Enterprise value Sector rank

76.14%
AUPH enterprise value is higher than 76.14% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

33.07
AUPH EV/EBITDA is 33.07

EV/EBITDA Sector rank

95.48%
AUPH EV/EBITDA is higher than 95.48% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.57
AUPH annual current ratio is 4.57

Quick ratio

4.17
AUPH annual quick ratio is 4.17

Leverage

Debt to equity

0.00
AUPH annual debt to equity ratio is 0.00

Interest coverage ratio

2.54
AUPH annual interest coverage ratio is 2.54

Risk & Stability

Piotroski F-Score

8
AUPH piotroski f-score is 8

Altman Z-Score

2.53
AUPH altman z-score is 2.53

Analyst ratings

Recent major analysts updates

Sep 16, 24 Cantor Fitzgerald
Overweight
Sep 9, 24 Cantor Fitzgerald
Overweight
Sep 6, 24 HC Wainwright & Co.
Buy
Mar 1, 24 HC Wainwright & Co.
Buy
Feb 23, 24 Cantor Fitzgerald
Overweight
Feb 22, 24 HC Wainwright & Co.
Buy
Feb 16, 24 RBC Capital
Outperform
Sep 22, 23 HC Wainwright & Co.
Buy
Aug 7, 23 HC Wainwright& Co.
Buy
Aug 7, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

AHCO logo
AdaptHealth (AHCO)
GPCR logo
Structure Therapeutics (GPCR)
BLFS logo
BioLife Solutions (BLFS)
USPH logo
US Physical Therapy (USPH)
VRDN logo
Viridian Therapeutics (VRDN)
EVH logo
Evolent Health (EVH)
INMD logo
InMode (INMD)
AMPH logo
Amphastar Pharmaceuticals (AMPH)
ARDX logo
Ardelyx (ARDX)
  • What is the ticker symbol for Aurinia Pharmaceuticals?
  • Does Aurinia Pharmaceuticals pay dividends?
  • What sector is Aurinia Pharmaceuticals in?
  • What industry is Aurinia Pharmaceuticals in?
  • What country is Aurinia Pharmaceuticals based in?
  • When did Aurinia Pharmaceuticals go public?
  • Is Aurinia Pharmaceuticals in the S&P 500?
  • Is Aurinia Pharmaceuticals in the NASDAQ 100?
  • Is Aurinia Pharmaceuticals in the Dow Jones?
  • When was Aurinia Pharmaceuticals's last earnings report?
  • When does Aurinia Pharmaceuticals report earnings?
  • Should I buy Aurinia Pharmaceuticals stock now?

What is the ticker symbol for Aurinia Pharmaceuticals?

The ticker symbol for Aurinia Pharmaceuticals is NASDAQ:AUPH

Does Aurinia Pharmaceuticals pay dividends?

No, Aurinia Pharmaceuticals does not pay dividends

What sector is Aurinia Pharmaceuticals in?

Aurinia Pharmaceuticals is in the Healthcare sector

What industry is Aurinia Pharmaceuticals in?

Aurinia Pharmaceuticals is in the Biotechnology industry

What country is Aurinia Pharmaceuticals based in?

Aurinia Pharmaceuticals is headquartered in Canada

When did Aurinia Pharmaceuticals go public?

Aurinia Pharmaceuticals's initial public offering (IPO) was on September 3, 2014

Is Aurinia Pharmaceuticals in the S&P 500?

No, Aurinia Pharmaceuticals is not included in the S&P 500 index

Is Aurinia Pharmaceuticals in the NASDAQ 100?

No, Aurinia Pharmaceuticals is not included in the NASDAQ 100 index

Is Aurinia Pharmaceuticals in the Dow Jones?

No, Aurinia Pharmaceuticals is not included in the Dow Jones index

When was Aurinia Pharmaceuticals's last earnings report?

Aurinia Pharmaceuticals's most recent earnings report was on Feb 27, 2025

When does Aurinia Pharmaceuticals report earnings?

The next expected earnings date for Aurinia Pharmaceuticals is May 2, 2025

Should I buy Aurinia Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page